Skip to main content
S&P 5007,765.36-0.47%DOW51,231.64+0.10%NASDAQ27,193.34-1.25%BTC$83,084.00+0.89%ETH$2,500.28-1.26%GOLD$4,201.70+1.08%OIL$91.22-0.30%
Smart Investors Daily
SID Premium
SR

NASDAQ · SRTS

Sensus Healthcare, Inc.

Healthcare · Medical - Devices

$2.97

Up+$0.03 (+1.02%)

Updated Oct 9, 2026, 1:10 PM

SID Score

4.1/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
63.07M
P/E ratio
-20.86
Dividend yield
0.00%
52-week range
$2.66 – $4.55
Volume
19.09K
Avg. volume
108.12K

Price performance · SRTS

SRTS price history

1M range · 0 trading sessions · Daily adjusted prices

SRTS does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest SRTS news

The latest Smart Investors Daily articles mentioning SRTS.

Stock researchCompany · Overview

SRTS research

Overview

Company profile and research snapshot.

Company profile

Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$10.00
Implied upside
—
Analysts
9
SRTS recent ratings
DateFirmRatingTarget
Aug 14, 2026Lake StreetBuy—
Feb 17, 2026Maxim GroupBuy—
Aug 12, 2025HC Wainwright & Co.Buy—
Aug 8, 2025Lake StreetBuy—
May 19, 2025Maxim GroupBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Feb 26, 2026

Sensus Healthcare Introduces Sensus Link, Brings Advanced Operating Capabilities to the SRT-100™ Installed Base

BOCA RATON, Fla., February 26, 2026--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, introduces Sensus Link, a cloud-based software and connectivity solution intended to expand advanced operating capabilities across the Company’s SRT-100™ system installed base.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By